Credit Suisse analyst Kaumil Gajrawala maintains Coca-Cola (NYSE:KO) with a Outperform and lowers the price target from $68 to $64.
What’s Going On With Lixte Biotechnology (LIXT) Stock?
LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares are roaring higher Monday.